Back to search
Primary Aldosteronism Due to Conn Adenoma
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Primary Aldosteronism Due to Conn Adenoma trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Primary Aldosteronism Due to Conn Adenoma trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
Primary aldosteronism (PA) is characterized by hypertension, frequent hypokalaemia, and an inappropriately high aldosterone-to-renin ratio (ARR). Aldosterone-pr…
This prospective, single-center study investigates the biodistribution, dosimetry, safety, diagnostic performance of Al18F-NOTA-Pentixafor PET imaging in patien…
This prospective observational study evaluates a simplified biochemical screening strategy to differentiate Glucocorticoid-Remediable Aldosteronism (GRA) from A…
The goal of this project is to improve the diagnostic pathway for patients with primary aldosteronism, by validating non-invasive biomarkers coupled with routin…